Speaker Profile
Chief Healthspan Officer, BioAro
Biography
Raman Kapoor, a Registered Dietitian, entrepreneur, philanthropist, and mother, is committed to advancing healthier communities through prevention and personalized care. As Chief Healthspan Officer at BioAro Inc., she leads efforts to integrate precision medicine into daily life, empowering individuals to take control of their health by tailoring solutions to their lifestyle, genetics, and microbiome.Raman is also the founder of NEA Precision Skin, where science and innovation come together to promote skin health as part of overall well-being. Additionally, she co-founded a wellness-focused charity that has positively impacted over 25,000 lives.With over 20 years of professional and volunteer experience, Raman emphasizes education and capacity building to inspire healthier, more confident living. Recognized with the Women of Inspiration Award for her contributions, she continues to champion healthspan optimization, helping individuals unlock their full potential for longevity and vitality.
Talk
MultiOmics and AI Unlock Peak Sports Performance
TheBioSport combines MultiOmics analysis and AI to revolutionize athletic performance. By leveraging genomics, microbiomics, and metabolomics, it provides personalized insights into an athletes physiology. AI-driven strategies optimize training, recovery, and nutrition, helping athletes achieve peak performance while reducing injury risk. This cutting-edge approach empowers excellence on and off the field.
Genomic Profiling Showcase:
BioAro
BioAro is a leading innovator in the fields of biotechnology, science, longevity and healthspan.
Each individual is unique, with a complex interplay of DNA, metabolism, microbiome, and lifestyle. BioAro has developed an ecosystem of tools to harness these complexities.
Session Abstract – PMWC 2025 Silicon Valley
The PMWC 2025 Genomic Profiling Showcase will provide a 15-30 min speaking opportunity for selected companies working with the latest technologies in nucleic acid sequencing such as NGS, providing instrumentation for genomic sequencing, and offering direct to consumer services. These companies will share their innovative products and services to an audience of leading investors, potential clients and partners. The Genomic Profiling Showcase will exhibit the latest innovations in methods and instruments used for DNA/ RNA sequencing to ascertain the genomic and transcriptional profile of a person in order to understand why some people get certain diseases while others do not, or why people react in different ways to the same drug. This information is also being used to develop new ways to diagnose, treat, and prevent diseases, such as cancer.
